THU521 - Use of Tocilizumab in patients with stable chronic liver disease and severe COVID-19 for prevention of decompensated cirrhosis, a prospective, open-label, randomized controlled trial.

Autor: Rosales Renteria, Luis Alejandro, Jaramillo-Ramírez, Hiram, Calderón-Mendieta, Francisco, Camacho-Escobedo, Jesús, Avendaño-Reyes, José Manuel, López-Rubio, Diana Laura, Araiza, Adrián Sández, Reyes-Higuera, Gisel Estefania, Soto-González, Dulce Renée, Arzola-Renteria, Erikc Jesús
Zdroj: In Journal of Hepatology July 2022 77 Supplement 1:S356-S356
Databáze: ScienceDirect
Externí odkaz: